In this review:
Faecal microbiota transplantation in UC
Drug non-adherence in UC
Adalimumab and infliximab levels in neonates
A home-based system (IBDoc®) for monitoring faecal calprotectin
IBDoc® results comparable to laboratory tests
The cost of newlydiagnosed IBD in Australia
Treatment and outcomes in the ECCO-EpiCom cohort
An IBD internet-based travel resource
Cyclosporine vs infliximab for acute severe steroidrefractory UC
Trichuris suis ova for CD
Safety and efficacy of anti-MAdCAM antibody in UC
Methotrexate for corticosteroid-dependent UC
Please login below to download this issue (PDF)